Kliniske studier for Melanom i Connecticut
13 studier for Melanom søker deltakere på steder i Connecticut.
Byer i Connecticut
Offisiell studietekst (engelsk)
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Yale Cancer Center, New Haven
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478Phase 1 Study of PF-08046033 in Advanced Solid Tumors
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- og 2 flere
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07519655A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Yale Cancer Center, New Haven
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06246916Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients
- Hartford Hospital, Hartford
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06284590A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Hartford Healthcare, Hartford
- Yale University, New Haven
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07070232Project: Every Child for Younger Patients With Cancer
- Connecticut Children's Medical Center, Hartford
- Yale University, New Haven
RekruttererObservasjonsstudie
Opp til 25 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT02402244Integrated Cancer Repository for Cancer Research
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- Yale School of Medicine, North Haven
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. apr. 2026 · NCT06413680SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Yale University, New Haven
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. feb. 2025 · NCT05669430Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Smilow Hospital Care Center, Guilford, Guilford
- Yale University, New Haven
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 27. nov. 2024 · NCT03860883Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Yale Cancer Center, New Haven
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. nov. 2024 · NCT04787042Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
- Yale, New Haven
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 18. mar. 2024 · NCT05280314Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.